These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 26597554)
21. Ocular Blood Flow and Normal Tension Glaucoma. Fan N; Wang P; Tang L; Liu X Biomed Res Int; 2015; 2015():308505. PubMed ID: 26558263 [TBL] [Abstract][Full Text] [Related]
22. Vascular risk factors in glaucoma: a review. Yanagi M; Kawasaki R; Wang JJ; Wong TY; Crowston J; Kiuchi Y Clin Exp Ophthalmol; 2011 Apr; 39(3):252-8. PubMed ID: 20973906 [TBL] [Abstract][Full Text] [Related]
23. Enhanced endothelium derived hyperpolarising factor activity in resistance arteries from normal pressure glaucoma patients: implications for vascular function in the eye. Cleary C; Buckley CH; Henry E; McLoughlin P; O'Brien C; Hadoke PW Br J Ophthalmol; 2005 Feb; 89(2):223-8. PubMed ID: 15665357 [TBL] [Abstract][Full Text] [Related]
24. The impact of ocular blood flow in glaucoma. Flammer J; Orgül S; Costa VP; Orzalesi N; Krieglstein GK; Serra LM; Renard JP; Stefánsson E Prog Retin Eye Res; 2002 Jul; 21(4):359-93. PubMed ID: 12150988 [TBL] [Abstract][Full Text] [Related]
30. [Perfusion pressure in ocular vessels of patients with open-angle glaucoma]. Bunin AIa; Mukha AI; Kolomoĭtseva EM Vestn Oftalmol; 1995; 111(1):28-31. PubMed ID: 7771039 [TBL] [Abstract][Full Text] [Related]
31. Effect of dorzolamide and timolol on ocular pressure: blood flow relationship in patients with primary open-angle glaucoma and ocular hypertension. Fuchsjäger-Mayrl G; Georgopoulos M; Hommer A; Weigert G; Pemp B; Vass C; Garhöfer G; Schmetterer L Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1289-96. PubMed ID: 19850848 [TBL] [Abstract][Full Text] [Related]
32. The circadian variations in systemic blood pressure, ocular perfusion pressure, and ocular blood flow: risk factors for glaucoma? Werne A; Harris A; Moore D; BenZion I; Siesky B Surv Ophthalmol; 2008; 53(6):559-67. PubMed ID: 19026319 [TBL] [Abstract][Full Text] [Related]
33. Vascular dysregulation: a principal risk factor for glaucomatous damage? Flammer J; Haefliger IO; Orgül S; Resink T J Glaucoma; 1999 Jun; 8(3):212-9. PubMed ID: 10376264 [TBL] [Abstract][Full Text] [Related]
34. Altered nitric oxide system in patients with open-angle glaucoma. Polak K; Luksch A; Berisha F; Fuchsjaeger-Mayrl G; Dallinger S; Schmetterer L Arch Ophthalmol; 2007 Apr; 125(4):494-8. PubMed ID: 17420369 [TBL] [Abstract][Full Text] [Related]
35. Primary open-angle glaucoma patients characterized by ocular vasospasm demonstrate a different ocular vascular response to timolol versus betaxolol. Evans DW; Harris A; Cantor LB J Ocul Pharmacol Ther; 1999 Dec; 15(6):479-87. PubMed ID: 10609770 [TBL] [Abstract][Full Text] [Related]
36. [Determination of individually endurable intraocular pressure (pressure of target) in primary glaucoma]. Shmyreva VF; Shmeleva-Demir OA; Mazurova IuV Vestn Oftalmol; 2003; 119(6):3-5. PubMed ID: 14708161 [TBL] [Abstract][Full Text] [Related]
37. [Endothelins and nitric oxide: their significance in the regulation of ocular blood flow and intraocular pressure and their role in the pathogenesis of primary glaucoma]. Bakshinskiĭ PP Vestn Oftalmol; 1999; 115(3):33-7. PubMed ID: 10432853 [No Abstract] [Full Text] [Related]
38. [Significance of Endothelin-1 in Glaucoma - a Short Overview]. Gugleta K Klin Monbl Augenheilkd; 2018 Feb; 235(2):140-145. PubMed ID: 29448283 [TBL] [Abstract][Full Text] [Related]
40. New insights in the pathogenesis and treatment of normal tension glaucoma. Mozaffarieh M; Flammer J Curr Opin Pharmacol; 2013 Feb; 13(1):43-9. PubMed ID: 23092679 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]